Contact
Please use this form to send email to PR contact of this press release:
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
TO:
Mina Sooch, CEO
Ocuphire Pharma, Inc.
+1 248-681-9815